studyId: syn51301409 diagnosis: Neurofibromatosis type 1 studyName: Leveraging patient-derived cutaneous neurofibroma organoid models to identify biomarkers of drug response accessType: Private initiative: Biology and Therapeutic Development for Cutaneous Neurofibromas fundingAgency: NTAP